Fielder Capital Group’s Elevance Health ELV Stock Holding History

Fielder Capital Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$323K	Sell	1,103 -113	-9%	-$37.1K	0.07%	182
2025 Q4	$426K	Buy	1,216 +30	+3%	+$10.1K	0.09%	133
2025 Q3	$383K	Sell	1,186 -112	-9%	-$34.8K	0.09%	138
2025 Q2	$505K	Sell	1,298 -202	-13%	-$81.2K	0.13%	103
2025 Q1	$653K	Buy	1,500 +186	+14%	+$74.7K	0.19%	75
2024 Q4	$485K	Sell	1,314 -148	-10%	-$61.9K	0.15%	100
2024 Q3	$760K	Buy	1,462 +58	+4%	+$31K	0.25%	67
2024 Q2	$761K	Sell	1,404 -6	-0.4%	-$3.17K	0.29%	60
2024 Q1	$731K	Buy	1,410 +9	+0.6%	+$4.48K	0.33%	53
2023 Q4	$661K	Buy	+1,401	New	+$648K	0.4%	54

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fielder Capital Group's ELV Position: Q1 2026 in Review

Fielder Capital Group reduced its Elevance Health (ELV) stake by 9.3% in Q1 2026, selling an estimated $37.1K and leaving 1,103 shares worth $323K. The position accounts for 0.07% of the portfolio, ranked #182.

Fielder Capital Group first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $761K in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Fielder Capital Group held 1,103 shares of Elevance Health worth $323K as of Q1 2026.
Fielder Capital Group sold 113 Elevance Health shares in Q1 2026, an estimated $37.1K.
Elevance Health made up 0.07% of Fielder Capital Group's portfolio in Q1 2026, its #182 holding.
Fielder Capital Group first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
Fielder Capital Group's Elevance Health position peaked at $761K in Q2 2024.
1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Fielder Capital Group's 13F filing for Q1 2026, filed 12 May 2026.